U.S. Semiconductors Stock News

NasdaqGS:FTAI
NasdaqGS:FTAIAerospace & Defense

Is It Too Late To Consider FTAI Aviation (FTAI) After Its Recent Share Price Surge

For readers wondering whether FTAI Aviation's current share price still offers value, or if most of the opportunity is already priced in, this article walks through what the numbers actually say. The stock recently closed at US$239.06, with returns of 3.9% over 7 days, a 21.8% decline over 30 days, 13.6% year to date, 114.6% over 1 year, and a very large gain over 3 years that is roughly 8x, as well as an even larger gain over 5 years. Recent coverage has focused on FTAI Aviation's position...
NYSE:REX
NYSE:REXOil and Gas

Why REX American Resources (REX) Is Up 23.3% After Record 2025 Earnings Powered By 45Z Tax Credits

REX American Resources reported past fourth-quarter 2025 sales of US$157.96 million, with net income rising to US$43.75 million, and full-year 2025 sales of US$650.49 million alongside net income of US$82.95 million. Record earnings per share, record ethanol sales volumes, substantial US$28.00 million in 45Z tax credits, and progress on capacity expansion and carbon capture projects collectively reshaped the company’s earnings mix and growth profile. We’ll now examine how record 2025...
NYSE:SOLV
NYSE:SOLVMedical Equipment

A Closer Look At Solventum (SOLV) Valuation After Recent Share Price Weakness

Framing Solventum after recent share price moves Solventum (SOLV) has come under pressure recently, with the share price weaker over the past week, month, and past 3 months. This has prompted investors to reassess how the healthcare group’s fundamentals line up with current market pricing. See our latest analysis for Solventum. At a current share price of US$62.76, Solventum’s recent 1 month share price return of 15.42% and year to date share price return of 20.58% suggest momentum has been...
NasdaqGS:MIDD
NasdaqGS:MIDDMachinery

Middleby CFO Change And Spin Off Plans Highlight Valuation Gap

Middleby has appointed Brittany Cerwin as its new Chief Financial Officer to lead the finance function during a major portfolio transformation. Outgoing CFO Bryan Mittelman will transition to a Special Advisor role and focus on the planned spin off of Middleby’s Food Processing business. The leadership change comes as Middleby prepares to position itself as a more focused commercial foodservice company. For investors watching NasdaqGS:MIDD, this leadership shift lands after a challenging...
NYSE:NHI
NYSE:NHIHealth Care REITs

How Investors Are Reacting To National Health Investors (NHI) Expanding Its At-the-Market Equity Program

Earlier this month, National Health Investors, Inc. filed an omnibus shelf registration covering common and preferred stock, debt securities, warrants, and units, and announced a US$500 million at-the-market follow-on common equity offering structured through an income trust. This combination of a sizable equity program and broad shelf capacity increases the REIT’s funding options and may influence how it balances growth investments with potential dilution and balance sheet...
NasdaqGS:BL
NasdaqGS:BLSoftware

A Look At BlackLine (BL) Valuation As Buybacks Rise And Growth Plans For 2026 Are Reaffirmed

BlackLine (BL) has just expanded its share repurchase authorization by US$100 million to US$500 million and added two directors, moves that frame how management is thinking about capital allocation and future execution. See our latest analysis for BlackLine. BlackLine’s share price has been under pressure, with a 1-day share price return showing a 4.02% decline and a 7-day share price return showing a 7.82% decline. The 1-year total shareholder return shows a 26.14% decline, indicating that...
NYSE:APD
NYSE:APDChemicals

A Look At Air Products And Chemicals (APD) Valuation After JPMorgan Upgrade And Helium Demand Tailwinds

Why JPMorgan’s upgrade is drawing attention to Air Products and Chemicals (APD) JPMorgan’s recent upgrade of Air Products and Chemicals (APD), tied to stable earnings and helium market support, has pushed the stock onto more investors’ radars, particularly among those monitoring industrial gases and energy related demand. See our latest analysis for Air Products and Chemicals. The recent upgrade comes after a period of building momentum, with a 90 day share price return of 17.89% and a year...
NYSE:GEF
NYSE:GEFPackaging

Is It Time To Reassess Greif (GEF) After Its Recent 25% One Year Gain?

If you are wondering whether Greif is offering fair value at its recent price, this breakdown will help you see how the current share level stacks up against several valuation checks. The stock recently closed at US$66.37, with a 6.0% return over the past 7 days, an 8.7% decline over 30 days, a 3.0% decline year to date, and a 25.2% gain over the past year, which may influence how you think about both upside potential and risk. Those swings sit alongside a longer track record, with returns...
NasdaqGS:LGN
NasdaqGS:LGNConstruction

Assessing Legence (LGN) Valuation After Recent Share Price Momentum And Revenue Multiple Signals

Recent price action and business context Legence (LGN) has drawn fresh attention after a recent share price move, with the stock closing at US$54.75 and showing mixed short term returns over the past week, month and past 3 months. For readers tracking the underlying business, Legence reports US$2.55b in revenue across engineering, installation and maintenance services for mission critical building systems in the United States. These operations are supported by two segments: Engineering &...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

A Look At Karman Holdings (KRMN) Valuation After A Strong Year And Recent Pullback

Recent performance snapshot Karman Holdings (KRMN) has drawn investor attention after a past year total return of about 140%, alongside a decline of nearly 5% over the past month and a gain of roughly 8% over the past three months. See our latest analysis for Karman Holdings. With the share price at $84.07, Karman Holdings has seen short term pressure, including a 15.4% decline in the 7 day share price return, while its 1 year total shareholder return of about 140% still signals strong longer...
NYSE:SIG
NYSE:SIGSpecialty Retail

Is It Time To Reassess Signet Jewelers (SIG) After The Recent Share Price Pullback?

Investors may be wondering if Signet Jewelers at around US$84 is still offering value, or if the easy money has already been made. The stock has pulled back recently, with a 5.6% decline over the last 7 days and a 12.6% decline over the last 30 days, even though the 1-year return sits at 45.1% and the 5-year return at 55.8%. This recent volatility comes after a period where Signet's share price performance over 3 years and 5 years has been positive overall. This can change how the market...
NYSE:TDW
NYSE:TDWEnergy Services

Tidewater Board Shift Anderson Exit Puts Governance In Investor Focus

Tidewater (NYSE:TDW) director Darron M. Anderson will step down from the board at the 2026 Annual Meeting. The board will shrink from eight to seven members after Anderson’s planned departure. Anderson is not seeking reelection and is expected to serve out his current term on the Audit and Safety & Sustainability Committees. The company states his decision is not related to any disagreement with management or board policies. Tidewater comes into this board change with its shares at $82.4...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Assessing Amicus Therapeutics (FOLD) Valuation After Strong Long Term Shareholder Returns

Context for the Recent Move in Amicus Therapeutics (FOLD) Recent trading in Amicus Therapeutics (FOLD) puts the spotlight back on how investors are weighing its rare disease portfolio against current financial metrics, including revenue, profitability, and multi year total returns. See our latest analysis for Amicus Therapeutics. At a share price of US$14.41, recent trading has been fairly muted over days and weeks. However, the 1 year total shareholder return of 70.94% and 5 year total...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Is It Too Late To Consider Nova (NVMI) After A 136% One Year Surge?

If you are wondering whether Nova's share price still offers value after a big run, or if you may be late to the story, this breakdown can help frame what the current market price might be implying. Nova closed at US$440.72, with returns of 26.9% year to date and 136.4% over the last year. Over the last 7 days and 30 days, the stock has seen more muted moves of a 5.3% decline and a 0.4% gain, respectively. Recent coverage around Nova has focused on its role in the semiconductor equipment...
NasdaqGS:ENTG
NasdaqGS:ENTGSemiconductor

Assessing Entegris (ENTG) Valuation After TurboQuant Concerns Hit Semiconductor Sentiment

Market reaction and governance changes set the stage Entegris (ENTG) quickly came into focus after sector wide selling linked to concerns over Google’s TurboQuant algorithm and its potential effect on memory demand, just as shareholders prepare to vote on governance changes. See our latest analysis for Entegris. At a share price of US$113.59, Entegris has seen a 30 day share price return of a 14% decline. However, its 90 day share price return of 32.17% and 1 year total shareholder return of...
NYSE:ADM
NYSE:ADMFood

ADM Pesticide Vote Tests ESG Transparency And Valuation Narrative

Shareholders have filed a proposal asking Archer-Daniels-Midland to disclose pesticide use data within its regenerative agriculture program. The proposal will be voted on at the upcoming annual general meeting. ADM has recommended that investors vote against the measure in its meeting materials. NYSE:ADM, recently trading at $72.23, has seen a 22.3% return year to date and a 56.2% return over the past year. The stock also shows a 44.1% return over five years, which keeps it on the radar for...